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Introduction {#sec1}
============

Phagocytes fight pathogens using canonical and noncanonical autophagy pathways ([@bib11]). Also known as LC3-associated phagocytosis (LAP), this form of noncanonical autophagy is a unique pathway that links signaling during phagocytosis with optimal degradation of the phagocytosed cargo via recruitment of the LC3-PE conjugation system required for lysosomal fusion and maturation of the LAPosome ([@bib46]). LAP, but not canonical autophagy, plays a critical role in the degradation of engulfed *Aspergillus* conidia ([@bib3], [@bib13], [@bib29], [@bib34], [@bib42], [@bib44]). Accordingly, mice defective for LAP exhibit increased fungal burden. These mice, however, also exhibited increased pathological inflammation and pro-inflammatory cytokine levels. Thus, as observed in murine and human chronic granulomatous disease (CGD), in which LAP is defective ([@bib13]), the inflammation and infectious susceptibility are all regulated by LAP. By allowing efficient pathogen clearance and/or degradation of inflammatory mediators ([@bib36]), cassettes of autophagy proteins may play a broad role in cellular and immune homeostasis ([@bib61]). Indeed, defects in autophagic machinery have been linked with aberrant host defense and inflammatory diseases ([@bib36], [@bib39], [@bib51]). For LAP, in particular, emerging evidence suggests that this pathway also regulates, among others ([@bib46]), dead cell clearance and inflammation ([@bib45]). Thus, understanding the molecular mechanisms underlying LAP ability to modulate the inflammatory response during autophagy may have therapeutic implications.

IFN-γ is an essential cytokine in the protective host response against fungi ([@bib52]) and has been implicated as a treatment option in invasive fungal infections ([@bib14], [@bib16]). In addition to its immunometabolic activity ([@bib8], [@bib53]), IFN-γ also induces degradative autophagy ([@bib4], [@bib22]) via recruitment of immunity-related GTPase ([@bib4], [@bib22], [@bib31], [@bib58]) as well as the death-associated protein kinase 1 (DAPK1) ([@bib18]). DAPK1 is a cell death-inducing Ca^2+^/calmodulin-regulated serine/threonine kinase, originally identified as an activator of IFN-γ-induced cell death ([@bib21]). DAPK1-induced expression by IFN-γ occurs through the transcription factor C/EBP-β in association with the key endoplasmic reticulum (ER) stress-activated transcription factor, ATF6 ([@bib18], [@bib27]). Recent findings have highlighted additional roles of this kinase beyond cell death ([@bib41]) that include a negative regulation of inflammation ([@bib35]) and attenuation of a variety of inflammatory responses in lung and airway injury ([@bib50]). Thus, DAPK1 could be an attractive player in the regulation of the inflammatory response during the process of fungal clearance initiated by IFN-γ.

In the present study, we have evaluated whether DAPK1 may contribute to dampening the inflammatory response during fungal LAP. To this purpose, we have resorted to a combination of basic and translational approaches involving selected deficient mice as well as human immunodeficiencies to establish that the ATF6/C/EBP-β/DAPK1 axis activated by IFN-γ not only mediates LAP to *A. fumigatus* but also regulates Nod-like receptor protein 3 (NLRP3) activation during infection. Genetic or functional DAPK1 deficiency increased inflammation and susceptibility to aspergillosis in high-risk patients. However, DAPK1 activity could be restored by IFN-γ. Thus, recognizing specific autophagy hallmarks triggered during infection may provide important insights into how autophagy and inflammation are integrated and reciprocally regulated to provide the optimal fungal clearance in the relative absence of immunopathology.

Results {#sec2}
=======

*Aspergillus fumigatus* Conidia Induce IFN-γ-Dependent DAPK1 Expression In Vitro and In Vivo {#sec2.1}
--------------------------------------------------------------------------------------------

In order to evaluate whether DAPK1 is induced in response to *A. fumigatus*, we monitored DAPK1 expression by RT-PCR, immunoblotting, and immunofluorescence staining either in vitro in RAW264.7 cells exposed to live conidia or in vivo in mice intranasally infected with the fungus. DAPK1 gene ([Figure 1](#fig1){ref-type="fig"}A) and protein ([Figures 1](#fig1){ref-type="fig"}B and 1C) expression was greatly upregulated at 4--6 hr of exposure to conidia, remained elevated till 10--12 hr, and declined thereafter. Germination of the fungus appeared to be required for DAPK1 expression to occur, being maximally induced by swollen conidia ([Figure 1](#fig1){ref-type="fig"}D). In vivo, DAPK1 gene ([Figure 1](#fig1){ref-type="fig"}E) and protein ([Figure 1](#fig1){ref-type="fig"}F) expression was increased during the first week of the infection in C57BL/6 mice. Consistent with the observation that DAPK1 is induced by IFN-γ ([@bib18]), IFN-γ exposure significantly enhanced DAPK1 expression in RAW264.7 cells ([Figures 1](#fig1){ref-type="fig"}A--1C), and DAPK1 expression was defective in *Ifng*^−/−^ mice in vivo ([Figures 1](#fig1){ref-type="fig"}E and 1F) and *Ifng*^−/−^ macrophages in vitro ([Figure 1](#fig1){ref-type="fig"}G). Of interest, exogenous IFN-γ restored DAPK1 expression in IFN-γ deficiency in vivo ([Figures 1](#fig1){ref-type="fig"}E and 1F) and in vitro ([Figure 1](#fig1){ref-type="fig"}G), a finding suggesting that signaling through the IFN receptor is required for DAPK1 activation.

Because innate and non-innate cells are capable of producing IFN-γ in response to fungi ([@bib52]), a paracrine action on myeloid cells for DAPK1 induction is likely. However, upon looking for IFN-γ expression and production by macrophages in response to the fungus, we found that IFN-γ gene expression increased in more than 85% of RAW264.7 cells after fungal exposure ([Figure 2](#fig2){ref-type="fig"}A) and was paralleled by increased protein production, as revealed by immunofluorescence ([Figure 2](#fig2){ref-type="fig"}B) and immunoblotting ([Figure 2](#fig2){ref-type="fig"}C). Similar results were obtained with purified lung macrophages ([Figures 2](#fig2){ref-type="fig"}D and 2E). The production of IFN-γ was functional, as evidenced by the upregulated expression of *IP10* gene ([Figure 2](#fig2){ref-type="fig"}F), and occurred in response to Dectin-1 and MyD88 signaling ([Figures 2](#fig2){ref-type="fig"}G and 2H) via NF-kB ([Figure 2](#fig2){ref-type="fig"}I). Because DAPK1 expression paralleled that of IFN-γ ([Figures 2](#fig2){ref-type="fig"}J and 2K), these results suggest that IFN-γ production upon Dectin-1/MyD88 recognition of the fungus may autocrinally activate DAPK1 in phagocytic cells.

DAPK1 Is Activated through the ATF6-C/EBP-β Pathway {#sec2.2}
---------------------------------------------------

The transcription factor C/EBP-β regulates transcription of DAPK1 in response to IFN-γ, in collaboration with ATF6, a key ER stress-activated transcription factor ([@bib18], [@bib19], [@bib27]). ER stress causes dissociation of ATF6 from its inhibitor, allowing its translocation from the ER membrane to the Golgi apparatus, where site-specific endoproteolysis generates transcriptionally active ATF6, permitting its nuclear entry and target gene regulation ([@bib55]). To evaluate the involvement of ATF6 and C/EBP-β in IFN-γ-dependent DAPK1 activation, we assessed ATF6 cleavage and C/EBP-β phosphorylation in RAW264.7 stimulated with IFN-γ and exposed to swollen conidia. Similar to tunicamycin, used as positive control ([@bib32]), the cleaved form of ATF6 was observed upon stimulation and was enhanced by IFN-γ, as revealed by immunoblotting ([Figure S1](#mmc1){ref-type="supplementary-material"}A, available online), immunofluorescence staining ([Figure S1](#mmc1){ref-type="supplementary-material"}B), and nuclear translocation ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Conidia also activated C/EBP-β phosphorylation ([Figure S1](#mmc1){ref-type="supplementary-material"}D) and its nuclear translocation ([Figure S1](#mmc1){ref-type="supplementary-material"}E), an activity potentiated by IFN-γ. All together, these results demonstrated that *A. fumigatus* conidia activated the IFN-γ-ATF6-C/EBP-β/DAPK1 pathway.

DAPK1 Contributes to LC3-Dependent *Aspergillus* Autophagy {#sec2.3}
----------------------------------------------------------

Increased accumulation of the autophagy marker GFP-LC3 in punctae representing the autophagosome membrane has been reported upon DAPK1 expression ([@bib38]). To evaluate the contribution of DAPK1 to *A. fumigatus*-induced LAP, we measured the LC3 punctae and the LC3B-II/LC3B-I ratio in RAW264.7 cells transiently transfected with the EGFP-LC3 plasmid, pulsed with swollen conidia, and depleted of DAPK1 by means of small interfering RNA (siRNA) or a chemical inhibitor. In line with previous observations ([@bib12], [@bib34]), the number of cells with punctate dots containing EGFP-LC3 increased ([Figures 3](#fig3){ref-type="fig"}A and 3B) upon phagocytosis of the fungus and was dependent on DAPK1, as did the ratio of LC3-II to LC3-I ([Figure 3](#fig3){ref-type="fig"}C). Not only did DAPK1 co-localize with LC3 in phagosomes containing conidia in more than 80% of cells, but not inert beads, which do not activate LAP ([@bib44], [@bib54]) ([Figure 3](#fig3){ref-type="fig"}D), but its functional inhibition, while not affecting fungal phagocytosis (data not shown), also decreased the number of LC3 punctae and the LC3B-II/LC3B-I ratio ([Figures 3](#fig3){ref-type="fig"}A--3C). The involvement of DAPK1 appeared to be selective for LAP, as DAPK1 co-localized with the LAP components Rubicon, Beclin-1, and Atg7 ([@bib44], [@bib54]) upon phagocytosis of conidia, but not beads, as revealed by cell immunofluorescence staining ([Figures 3](#fig3){ref-type="fig"}D and [S2](#mmc1){ref-type="supplementary-material"}) and immunoblotting of purified phagosomes ([Figures 3](#fig3){ref-type="fig"}E and 3F). Consistent with the requirement of NOX2 for LAP ([@bib44]), silencing of Rubicon and NOX2, in addition to Beclin-1 and Atg7, with specific siRNA abrogated DAPK1\'s recruitment on phagosomes ([Figures 3](#fig3){ref-type="fig"}G and [S6](#mmc1){ref-type="supplementary-material"}), suggesting that retention of DAPK1 on *Aspergillus*-containing phagosomes depends on the essential LAP protein Rubicon and additional autophagy proteins. Confirming the involvement of DAPK1 in LAP to the fungus, DAPK1 inhibition did not affect rapamycin-induced autophagy ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B), a finding confirming that DAPK1 is not involved in starvation-induced autophagy ([@bib20]). This finding is important, given that IFN-γ could activate autophagy through tryptophan starvation via the indoleamine 2,3-dioxygenase (IDO)1 enzyme ([@bib47]). In this regard, we found that IFN-γ-induced autophagy was defective in *Indo*^−/−^ macrophages and not modified by the DAPK1 inhibitor ([Figure S3](#mmc1){ref-type="supplementary-material"}C). In contrast, LC3-dependendent phagocytosis of the fungus was observed in *Indo*^−/−^ macrophages in vitro ([Figure S3](#mmc1){ref-type="supplementary-material"}D), and DAPK1 expression increased in *Indo*^−/−^ mice upon infection in vivo ([Figure S3](#mmc1){ref-type="supplementary-material"}E). Blocking DAPK1 greatly increased the fungal burden and the dissemination in infected *Indo*^−/−^ mice ([Figure S3](#mmc1){ref-type="supplementary-material"}F), as well as the inflammatory cell recruitment in the lung and the bronchoalveolar lavage fluid ([Figures S3](#mmc1){ref-type="supplementary-material"}G and S3H), a finding indicating that the starvation-induced autophagy and LAP are distinct, yet complementary, pathways in fungal clearance. Altogether, these results point to DAPK1 as an important effector molecule mediating IFN-γ-dependent LAP and the ensuing fungal clearance.

DAPK1 Activates the Proteasomal Degradation Pathway during LAP to Inhibit NLPR3 {#sec2.4}
-------------------------------------------------------------------------------

These results were corroborated by strong acidification ([Figure 4](#fig4){ref-type="fig"}A) and LAMP-1 (lysosomal-associated membrane protein 1) positivity ([Figure 4](#fig4){ref-type="fig"}B) in conidia-containing vacuoles, indicating fusion with lysosomes. Interestingly, and quite surprisingly, both acidification and LAMP-1 positivity were unaffected, if not increased, upon DAPK1 inhibition ([Figures 4](#fig4){ref-type="fig"}A and 4B), a finding suggesting that the lysosomal degradative pathway of fungal clearance was relatively independent from DAPK1.

The ubiquitin- and adaptor p62-dependent autophagic targeting of damaged membranes that occurs during pathogen phagocytosis has been shown to help to control detrimental downstream signaling during bacterial invasion into host cells ([@bib9], [@bib17], [@bib64]). Given the pleiotropic cellular effects of DAPK1 beyond kinase activity ([@bib41]), which include degradation through ankyrin repeats ([@bib57]), we tested whether DAPK1 could control the activation of the proteasomal degradation pathway during fungal clearance. We have recently found that this pathway crucially regulates NLRP3 inflammasome activity in response to the fungus that serves to curb inflammation ([@bib25]). We found decreased cellular ubiquitination ([Figure 4](#fig4){ref-type="fig"}C), increased p62 expression ([Figures 4](#fig4){ref-type="fig"}D and 4E), and proteasomal degradation ([Figure 4](#fig4){ref-type="fig"}F) upon inhibition of DAPK1 in RAW264.7 cells or ex vivo phagocytes exposed to conidia in the presence of IFN-γ, a finding suggesting that the ubiquitin/proteasomal pathway is activated during fungal LAP and that DAPK1 is an active player. We looked therefore for NLRP3 expression and activity in RAW264.7 cells exposed to the fungus in vitro as well as in infection in vivo upon DAPK1 inhibition. We found that NLRP3 expression and caspase-1 cleavage were increased in vitro ([Figures 5](#fig5){ref-type="fig"}A and 5B). Ubiquitin-mediated proteasomal processing of NLRP3 involves the FBXO3 E3 ligase component that targets FBXL2, which robustly catalyzes NLRP3 ubiquitination ([@bib23]). The increased NLRP3 activity upon DAPK1 inhibition correlated with decreased NLRP3 ubiquitination ([Figures 5](#fig5){ref-type="fig"}C and [S4](#mmc1){ref-type="supplementary-material"}) and decreased binding of FBXL2 to NLRP3 ([Figure 5](#fig5){ref-type="fig"}D). In vivo, DAPK1 inhibition with the chemical inhibitor or siRNA ([Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}) was associated with increased NLRP3 expression ([Figure 5](#fig5){ref-type="fig"}E), caspase-1 cleavage ([Figure 5](#fig5){ref-type="fig"}F), IL-1β/IL-18 production and *Mpo* expression ([Figure 5](#fig5){ref-type="fig"}G), increased fungal load ([Figure 5](#fig5){ref-type="fig"}H), and tissue inflammation ([Figure 5](#fig5){ref-type="fig"}I), likely due to defective autophagy ([Figure 5](#fig5){ref-type="fig"}J). These effects were not observed in *Nlrp3*^−/−^ mice treated with the DAPK1 inhibitor ([Figures 5](#fig5){ref-type="fig"}K and 5L), confirming that NLRP3 mediates the downstream effects on inflammation of DAPK1. Despite the ability of DAPK1 to regulate cell apoptosis via Bcl-2 expression ([@bib1]), lung apoptosis was apparently unaffected upon DAPK1 inhibition ([Figure 5](#fig5){ref-type="fig"}H). These findings indicate that DAPK1 activation during LAP may restrain pathogenic NLRP3 activity in response to the fungus, likely impacting local inflammation.

IFN-γ Restores Defective DAPK1 in CGD {#sec2.5}
-------------------------------------

The above results prompted us to evaluate whether the ability of IFN-γ to activate DAPK1 could be therapeutically exploited. To this purpose, we assessed DAPK1 expression and its modulation by IFN-γ in murine and human CGD, in which both defective autophagy and increased inflammasome activity have been described ([@bib13]). DAPK1 gene and protein expression was defective in *p47*^*phox*−/−^ infected mice ([Figures 6](#fig6){ref-type="fig"}A and 6B) and in vitro in both *p47*^*phox*−/−^ lung macrophages ([Figures 6](#fig6){ref-type="fig"}C--6E) and monocytes from CGD patients ([Figure 6](#fig6){ref-type="fig"}F). IFN-γ protein expression ([Figure 6](#fig6){ref-type="fig"}G) and production ([Figure 6](#fig6){ref-type="fig"}H) were also defective in CGD cells, a finding indicating that reactive oxygen species (ROS) are upstream signals for IFN-γ induction. Of great interest, treatment with IFN-γ restored DAPK1 expression ([Figures 6](#fig6){ref-type="fig"}A and 6B), reduced the fungal growth ([Figure 6](#fig6){ref-type="fig"}I), and decreased IL-1β production ([Figure 6](#fig6){ref-type="fig"}J) in infection. Similarly, in vitro, IFN-γ restored DAPK1 expression (from \<5% to up 90% double positive cells after treatment) ([Figures 6](#fig6){ref-type="fig"}C--6E) and decreased inflammation in murine ([Figure 6](#fig6){ref-type="fig"}K) and human CGD mononuclear cells ([Figures 6](#fig6){ref-type="fig"}F, 6L, and 6M), a finding suggesting the drugability of DAPK1 in CGD by IFN-γ therapy. Incidentally, our unpublished observations suggest that anakinra, known to decrease NLRP3 activity and restore LAP in both murine and human CGD cells ([@bib13]), also activates DAPK1.

DAPK1 Polymorphisms Affect Susceptibility to Aspergillosis in Hematopoietic Transplanted Patients {#sec2.6}
-------------------------------------------------------------------------------------------------

Although aspergillosis remains a major cause of morbidity and mortality in CGD patients ([@bib43]), it is a much more common problem in hematopoietic stem cell transplantation (HSCT) patients ([@bib24]). We therefore assessed the impact of DAPK1 in this setting by analyzing five *DAPK1* SNPs in a cohort of HSCT patients. In the univariate analysis, applying a general genetic model, none of the *DAPK1* SNPs significantly associated with an increased incidence of infection, either in recipients or in donors ([Table S1](#mmc1){ref-type="supplementary-material"}). However, the *DAPK1* rs1964911 SNP, located on the promoter region, showed a trend for association in recipients (p = 0.066). Indeed, by testing the association of rs1964911 using a recessive genetic model, the C/C genotype turned out to be significantly associated with an increased incidence of aspergillosis in recipients (30.2% for C/C and 16.2% for A carriers, p = 0.029) ([Figure 7](#fig7){ref-type="fig"}A), but not in donors (24.2% for C/C and 16.7% for A carriers, p = 0.219). The analysis of *DAPK1* rs1964911 recessive recipient/donor combination further confirmed the effect of C/C genotype in increasing the risk of infection, especially when present simultaneously in both recipients and donors (42.1% for C/C pairs versus 17.4% for A carriers pairs, p = 0.029) ([Figure 7](#fig7){ref-type="fig"}B). The association of C/C genotype with increased risk of infection remained statistically significant after adjusting for HLA-matching status, underlying disease, and antifungal prophylaxis (donors, RR = 1.873, p = 0.036; donors/recipients combined, RR = 2.184, p = 0.027). Functional studies in vitro revealed that both DAPK1 gene ([Figure 7](#fig7){ref-type="fig"}C) and protein ([Figures 7](#fig7){ref-type="fig"}D and 7E) were defective in peripheral mononuclear cells from patients with the C/C genotype, while NLRP3 expression ([Figure 7](#fig7){ref-type="fig"}F) and IL-1β production ([Figure 7](#fig7){ref-type="fig"}G) were increased. Thus, genetic deficiency of *DAPK1* may contribute to the risk of invasive aspergillosis in HSCT patients.

Discussion {#sec3}
==========

The results of the present study identify a host defense pathway controlled by IFN-γ signaling. We found that IFN-γ not only mediated LAP to *A. fumigatus* but also regulated NLRP3 activation during infection. The importance of LAP for fungal clearance ([@bib34], [@bib44], [@bib59]) and its subversion by fungal melanin ([@bib3]) have been recently described. However, inflammation has to be controlled under microbial autophagy in the lung to prevent pulmonary overreaction ([@bib28]). We found the DAPK1 may serve this function. The DAPK1 interactome has shown that DAPK1, by participating in several signaling cascades by means of its catalytic activity and protein-protein interactions ([@bib6]), mediates various cellular effects. This may explain the complex role of DAPK1 in the regulation of inflammation, which is likely dependent on cell types and environment ([@bib35]). Indeed, while DAPK1 deficiency attenuated inflammasome-induced peritonitis ([@bib10]), it increased LPS-induced inflammation in the lung, an activity dependent upon its inflammation-suppressive functions rather than the prevention of the inflammatory cell recruitment ([@bib50]). Consistently, DAPK1 was shown to activate the translational silencing of various inflammatory genes in response to IFN-γ ([@bib48]). Our study expands upon the molecular mechanisms by which DAPK1 regulates the inflammatory response in the lung by showing that it inhibits NLRP3 activity by promoting its proteasomal degradation via FBXL2, as reported ([@bib23]). This finding is only apparently in contrast with what was observed in 293T cells, where DAPK1 served a structural role in the assembly of the NLRP3 inflammasome ([@bib10]). Indeed, the DAPK1 requirement for NLRP3 activation was stimulus dependent; NLRP3 activity was ablated upon DAPK deficiency in response to TLR2 and TLR7, but not TLR4 signaling ([@bib10]). As a matter of fact, LPS-induced intestinal inflammation was increased in DAPK1 deficiency in mice ([@bib50]) and humans where enhanced severity of gut inflammation and ulcerative colitis was observed ([@bib33]). Promotion of NLRP3 activity was meant to contribute to DAPK1-induced cell death ([@bib10]), an activity that we have not seen in the lung. Therefore, DAPK1 activation initiated by IFN-γ may serve a unique role in the lung by tightly regulating inflammasome activity during fungal LAP through a mechanism that is shared with autophagy ([@bib56]).

The ubiquitin-proteasomal pathway appeared to be involved in this process, for both cellular ubiquitination and adaptor p62 expression were decreased or increased, respectively, after DAPK1 inhibition. That the ubiquitin-like conjugation system of the autophagy pathway, but not the canonical degradative autophagy process, is required for IFN-γ-induced LAP in intracellular infection has been reported ([@bib9]). Interestingly, we have found that conidia may undergo ubiquitination during phagocytosis ([Figure 4](#fig4){ref-type="fig"}A), a finding suggesting the occurrence of xenophagy, a process that targets intravacuolar microbes for ubiquitination followed by recruitment of, among others, p62 adaptor protein and LC3, and leading to autophagosome fusion with lysosomes for degradation ([@bib9], [@bib15]). In this regard, we have already shown that inhibitors of both the lysosomal and proteasomal pathways negatively affected the ability of phagocytes to control intracellular fungal growth ([@bib25]). Precisely how the ubiquitin-proteasomal degradative pathway is activated by DAPK1 to inhibit NLRP3, and whether the activation of the immunoproteasome by IFN-γ ([@bib2]) is also involved, remains to be determined. It is nevertheless of interest that the ankyrin repeats of DAPK1 may bind E3 ubiquitin ligases ([@bib26]) and that the immunoproteasome is implicated in fungal pathogenicity ([@bib49]) and lung responses to infections ([@bib30]).

IFN-γ, produced by innate and adaptive lymphocytes, plays a critical role in mediating protection against fungi ([@bib52]). The results of the present study show that macrophages are alternative sources of IFN-γ produced upon Dectin-1/MyD88 stimulation and ROS signaling, a finding suggesting that early production of IFN-γ by macrophages may occur in the relative absence of innate or adaptive immune cells and, as such, be exploitable in selected immunodeficiencies. Combined with antifungal drug therapy, immunotherapy with IFN-γ represents a treatment option in patients at risk for fungal infections ([@bib62], [@bib5], [@bib7], [@bib14], [@bib16], [@bib60]). The results of the present study increase our understanding of the immunopharmacology of IFN-γ in infection treatment that now includes an activity on DAPK1. This may have therapeutic implications given that DAPK expression and activity are deregulated in a variety of diseases including cancer ([@bib40]). We have found that DAPK1 activity was defective in CGD but restored by IFN-γ. We have also found that genetic DAPK1 deficiency increased inflammation and susceptibility of HSCT patients to aspergillosis. These findings, while reinforcing the therapeutic utility of IFN-γ in human CGD, also suggest a possible IFN-γ recommendation in transplanted patients.

In conclusion, it appears that IFN-γ, through its multitasking activity encompassing immune tolerance via the IDO1 pathway ([@bib53]), immunometabolic activity ([@bib8], [@bib37]), and, now, optimal microbial clearance through the DAPK1-LAP pathway, fulfills the requirement of an ideal candidate player at the host-fungi interface.

Experimental Procedures {#sec4}
=======================

Detailed experimental procedures can be found in the [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Mice {#sec4.1}
----

Mice, 8--10 weeks old, were purchased from Charles River or bred at the Animal Facility of Perugia.

Fungal Strains, Infections, and Treatments {#sec4.2}
------------------------------------------

For infection, mice received intranasal instillation of *A. fumigatus* conidia. A total of 20,000 U/mouse IFN-γ was given daily starting the day of the infection until the sacrifice. DAPK inhibitor was administered intranasally at the dose of 500 μg/kg for 5 days starting 3 days before the infection. For *Dapk1* silencing, mice received intranasal administration of 10 mg/kg *Dapk1* siRNA.

Cell Preparation, Culture, and Transfection {#sec4.3}
-------------------------------------------

RAW264.7 and RAW-GFP-LC3 cells were grown in supplemented RPMI medium as described ([@bib12]). Alveolar macrophages from mice lung were isolated after plastic adherence at 37°C. Cells were pretreated overnight with 200 U/mL rIFN-γ before pulsing with *A. fumigatus* resting or swollen conidia. For DAPK1 inhibition, cells were pretreated with 3 μM DAPK inhibitor as described ([@bib63]). Rapamycin was used at 50 μM. For NF-kB inhibition, SN50 was used at 18 μM for 1 hr before *A. fumigatus* pulsing. For in vitro silencing, cells were transfected with 40 nM specific siRNAs before *A. fumigatus* or inert bead stimulation.

Immunoblotting and Immunoprecipitation {#sec4.4}
--------------------------------------

For immunoprecipitation, the lysates were incubated with anti-ubiquitin, anti-FBXL2 antibody, and Protein G Sepharose beads. For immunoblotting, the lysates were incubated with the following antibodies: DAP kinase 1, ATF6; C/EBPβ and p-C/EBPβ, LC3B, SQSTM1/p62, FBXL2, HA, ubiquitin, caspase-1 p10, IFN-γ, Lamin B1, NLRP3, and caspase-1. Phagosomes from RAW264.7 cells were obtained as described ([@bib44]) and the proteins were probed with DAP kinase 1, LC3B, Beclin-1, Rubicon, and Atg7.

ELISA and Real-Time PCR {#sec4.5}
-----------------------

Cytokines in lung homogenates or cell culture supernatants was determined by specific ELISAs (R&D Systems). Real-time RT-PCR was performed using SYBR Green chemistry (Biorad).

Immunofluorescence and Acridine Orange Staining {#sec4.6}
-----------------------------------------------

Fixed cells were incubated with DAPK1, ATF6, C/EBPβ, p-C/EBPβ, IFN-γ, LC3B, SQSTM1/p62, LAMP1, NLRP3, and ubiquitin antibodies. Acridine orange was used to detect the cellular acidic compartment by measuring the red fluorescence emission.

Human Studies {#sec4.7}
-------------

### Isolation and Culture of Monocytes from Human PBMCs {#sec4.7.1}

Monocytes were isolated from peripheral blood mononuclear cells (PBMCs) of healthy donors or two CGD patients, harboring the mutations c.736C\>T, p.Q246X and whole CYBB gene deletion (69.84 kb). Cells were cultured for 4 hr with live *A. fumigatus* conidia in the presence of 200 U/mL rIFN-γ before assays.

### Patients {#sec4.7.2}

The genetic study included 277 patients undergoing allogeneic HSCT and their respective donors (who were related in 98% of cases). Patient characteristics are summarized in [Table S1](#mmc1){ref-type="supplementary-material"}.

SNP Selection and Genotyping {#sec4.8}
----------------------------

Five *DAPK1* SNPs complied with the selection criteria: rs1964911, rs4878104, rs4877365, rs7025760, and rs1056719. Genotyping was performed using KASPar assays.

Statistical Analysis {#sec4.9}
--------------------

Data are expressed as mean ± SD. p values were calculated by a one-way ANOVA (Bonferroni's post hoc test). For single comparison, p values were calculated by a two-tailed Student's t test. The probability of IA according to DAPK1 variants was determined with the use of the cumulative incidence method, and DAPK1 status among patients with and without infection was compared with the use of Gray's test. Cumulative incidences were computed with R software.

Author Contributions {#sec5}
====================

V.O. and G.R. performed most of the in vitro experiments; M.B. performed murine in vivo experiments; M. Pariano performed some immunofluorescence experiments; M. Puccetti and C.G. performed SNP analysis and V.N. analyzed and compiled the SNP data; L.A., A.C., L.P., A.S., and A.F. followed patients and provided clinical samples; and V.O., S.M., C.A.P., P.R., A.V., F.A., and L.R. designed the experiments, analyzed the data, and wrote the paper.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures, Figures S1--S6, and Table S1Document S2. Article plus Supplemental Information

This study was supported by the Specific Targeted Research Project FunMeta (ERC-2011-AdG-293714 to L.R.).

Supplemental Information includes Supplemental Experimental Procedures, six figures, and one table and can be found with this article online at [http://dx.doi.org/10.1016/j.chom.2016.10.012](10.1016/j.chom.2016.10.012){#intref0010}.

![*A. fumigatus* Conidia Induce IFN-γ-Dependent DAPK1 Expression In Vitro and In Vivo\
(A--C) DAPK1 gene expression (A) and production by immunoblotting (B) and immunofluorescence (C) in RAW264.7 cells pulsed with live *A. fumigatus* conidia in the presence of rIFN-γ.\
(D) DAPK1 expression in C57BL/6 lung macrophages after exposure to *A. fumigatus* heat-inactivated resting conidia (RC), swollen conidia (SC), or hyphae.\
(E and F) DAPK1 gene (E) and protein (F) expression in lung of mice either uninfected (0 dpi, days post-infection) or infected with *A. fumigatus* conidia and treated with rIFN-γ.\
(G) Immunoblotting of DAPK1 in purified lung macrophages exposed to live *A. fumigatus* conidia in vitro in the presence of rIFN-γ. *Dapk1* gene expression was assessed by real-time qPCR and normalized on Gapdh.\
For immunoblotting, normalization was performed on mouse β-actin (the corresponding pixel densities are indicated). For immunofluorescence, nuclei were counterstained with DAPI. Photographs were taken with a high-resolution microscope (Olympus BX51). Scale bars, 25 μm. DAPK1 fluorescence intensity was measured with the ImageJ software; BF, brightfield. Data (mean values ± SD) represent pooled results or representative images (immunofluorescence and immunoblotting) from three experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001, rIFN-γ treated versus untreated RAW264.7 cells and rIFN-γ treated versus untreated *Ifng*^−/−^ mice. None, unpulsed and/or untreated cells. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![*A. fumigatus* Conidia Induce IFN-γ Production In Vitro and In Vivo\
(A--C) IFN-γ gene expression (A) and production by immunofluorescence (B) and immunoblotting (C) in RAW264.7 cells pulsed with live *A. fumigatus* conidia.\
(D and E) IFN-γ production by immunoblotting (D) and ELISA (E) in C57BL/6 lung macrophages exposed to live *A. fumigatus* conidia.\
(F) *IP10* gene expression in RAW264.7 cells pulsed with live conidia in the presence of rIFN-γ.\
(G and H) IFN-γ production by immunoblotting (G) and ELISA (H) in lung macrophages from C57BL/6, *Dectin1*^−/−^, or *Myd88*^−/−^ mice exposed to conidia.\
(I) Immunoblotting of IFN-γ in RAW264.7 cells exposed to conidia and treated with the NF-kB inhibitor, SN50.\
(J and K) *Dapk1* gene (J) and protein (K) expression in lung macrophages stimulated as above. Gene expression was assessed by real-time qPCR (normalization was performed on Gapdh).\
For immunoblotting, normalization was performed on mouse β-actin or Gapdh (the corresponding pixel density is indicated). For immunofluorescence, nuclei were counterstained with DAPI. Photographs were taken with a high-resolution microscope (Olympus BX51). Scale bars, 100 μm. IFN-γ fluorescence intensity was measured with the ImageJ software. Data (mean values ± SD) represent pooled results or representative images (immunofluorescence and immunoblotting) from three experiments. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001, conidia-pulsed versus unpulsed (none) or rIFN-γ treated versus untreated cells and knockouts versus wild-type mice.](gr2){#fig2}

![DAPK1 Contributes to LC3-Dependent *Aspergillus* Autophagy\
(A and B) GFP-LC3 punctae accumulation (A) (immunofluorescence) and percentage of GFP-LC3-positive cells (B) in RAW-GFP-LC3 cells after 1 hr stimulation with live *A. fumigatus* conidia + rIFN-γ in the presence of the DAPK inhibitor, *Dapk1*-specific siRNA (si*Dapk1*), or negative control (Mock).\
(C) LC3B-II/LC3B-I expression in RAW264.7 cells stimulated as above.\
(D) Immunofluorescence imaging of RAW-GFP-LC3 or RAW264.7 cells pulsed with *A. fumigatus* conidia or inert beads in the presence of rIFN-γ.\
(E--G) Purified phagosomes from RAW264.7 cells were pulsed with *A. fumigatus* conidia or inert beads for 1 hr in the presence of rIFN-γ or the indicated siRNAs to evaluate DAPK1 (E and G), Rubicon, Atg7, Beclin-1, and LC3B-II (F) expression by immunoblotting.\
For immunofluorescence, nuclei were counterstained with DAPI. For immunoblotting, normalization was performed on mouse Gapdh (the corresponding ratio is indicated). Photographs were taken with a high-resolution microscope (Olympus BX51). Scale bar, 25 μm. BF, brightfield. Numbers refer to co-localization coefficients to quantify the overlap degree of DAPK1 and Beclin-1, Rubicon and Atg7. Data (mean values ± SD) represent pooled results or representative images (immunofluorescence and immunoblotting) from three experiments. ^∗∗∗^p \< 0.001, DAPK inhibitor or si*Dapk1* treated versus untreated RAW-GFP-LC3 cells. None, unpulsed and untreated cells. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![DAPK1 Activates the Proteosomal Degradation Pathway during LAP\
(A and B) Acridine orange (A) and Lamp-1 (B) immunofluorescence staining in RAW264.7 cells pulsed with *A. fumigatus* conidia + rIFN-γ in the presence of the DAPK inhibitor. Acridine orange emits red or green fluorescence in acidic or neutral environments, respectively.\
(C--E) Ubiquitin (C), SQSTM1/p62 immunoblotting (D), and SQSTM1/p62 (E) immunofluorescence staining in cells pulsed as above.\
(F) Fluorometric quantification of proteosomal activity in RAW264.7 cells, lung macrophages, and neutrophils stimulated as above. Succ-LLVY-AMC, proteasome substrate that releases AMC-tagged peptide substrate in the presence of proteolytic activity.\
For immunoblotting, normalization was performed on mouse β-actin (the corresponding pixel density is indicated). For immunofluorescence, nuclei were counterstained with DAPI. Photographs were taken with a high-resolution microscope (Olympus BX51). Scale bars, 100 and 25 μm. Arrows indicate conidia. Lamp-1 fluorescence intensity was measured with the ImageJ software. Data (mean values ± SD) represent pooled results or representative images (immunofluorescence and immunoblotting) from three experiments. ^∗∗∗∗^p \< 0.0001, DAPK inhibitor treated versus untreated cells. None, unpulsed and untreated cells.](gr4){#fig4}

![DAPK1 Activates FBXL2-Dependent NLRP3 Degradation\
(A and B) NLRP3 (A) and caspase-1 (B) expression in RAW264.7 cells stimulated with *A. fumigatus* conidia + rIFN-γ in the presence of the DAPK inhibitor.\
(C and D) Ubiquitin (C) and FBXL2 (D) immunoprecipitation followed by NLRP3, FBXL2, and ubiquitin immunoblotting.\
(E--J) C57BL/6 mice were infected with *A. fumigatus* live conidia, treated with the DAPK1 inhibitor, and assessed (at 3 dpi) for NLRP3 expression (E), caspase-1 cleavage (F), cytokine production (ELISA on lung homogenates), *Mpo* expression on total lung cells (G), fungal burden (H), lung pathology (by PAS staining and Tunel assay) (I), and LC3B-II/LC3B-I ratio on total lung cells (J).\
(K and L) Fungal burden (K) and lung pathology (L) (PAS staining) in *Nlrp3*^−/−^ mice infected and treated as above.\
For immunoblotting, normalization was performed on mouse β-actin or Gapdh and corresponding pixel density or ratio is depicted. For immunofluorescence, nuclei were counterstained with DAPI. Photographs were taken with a high-resolution microscope (Olympus BX51). Scale bars, 100 μm. Data (mean values ± SD) represent pooled results or representative images (immunofluorescence and immunoblotting) from three experiments. ^∗∗^p \< 0.01, DAPK inhibitor treated versus untreated RAW264.7 cells or mice. Naive, uninfected mice. See also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.](gr5){#fig5}

![IFN-γ Restores Defective DAPK1 in CGD\
(A and B) C57BL/6 and *p47*^*phox*−/−^ mice were infected with *A. fumigatus* conidia, treated with rIFN-γ, and assessed at the indicated days post-infection (dpi) for Dapk1 gene (A) and protein (B) expression.\
(C and D) Dapk1 gene (C) and protein (D) expression in lung macrophages from C57BL/6 and *p47*^*phox*−/−^ mice after pulsing with *A. fumigatus* conidia in the presence of rIFN-γ.\
(E and F) LC3B and DAPK1 expression in macrophages (E) from *p47*^*phox*−/−^ mice and monocytes (F) from CGD patients stimulated as in (C).\
(G and H) IFN-γ expression (G) and production (H) on purified lung macrophages exposed to *A. fumigatus* conidia in vitro.\
(I and J) Fungal burden (I) and IL-1β production (J) (ELISA on lung homogenates) evaluated at 3 dpi in C57BL/6 and *p47*^*phox*−/−^ mice infected and treated as above.\
(K) IL-1β production (ELISA on culture supernatant) in lung macrophages from C57BL/6 and *p47*^*phox*−/−^ treated as in (C).\
(L and M) NLRP3 (L) and caspase-1 cleavage (M) in monocytes from healthy control (Ct) or CGD patients pulsed with *A. fumigatus* conidia in the presence of rIFN-γ.\
For immunoblotting, normalization was performed on mouse β-actin or Gapdh and corresponding pixel density or ratio is depicted. For immunofluorescence, nuclei were counterstained with DAPI. Photographs were taken with a high-resolution microscope (Olympus BX51). Scale bars, 25 μm. Data (mean values ± SD) represent pooled results or representative images (immunofluorescence and immunoblotting) from three experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001, rIFN-γ treated versus untreated cells or mice. None, unpulsed and untreated cells.](gr6){#fig6}

![*DAPK1* rs1964911 Is Associated with Increased Risk of Invasive Aspergillosis in HSCT Recipients\
(A and B) Cumulative incidence of invasive aspergillosis at 24 months in recipients (C/C versus A carriers, p = 0.029) (A) and cumulative incidence of invasive aspergillosis at 24 months in recipient/donor combination (B) (full model, p = 0.029).\
(C--G) *DAPK1* gene expression (C) and production (D and E), NLRP3 expression (F), and IL-1β production (G) in macrophages isolated from peripheral mononuclear blood cells of subjects carrying diverse genotypes at rs1964911 stimulated with *A. fumigatus* conidia.\
Normalization was performed on Gapdh for real-time PCR and on human β-actin for immunoblotting. For immunofluorescence, nuclei were counterstained with DAPI. Photographs were taken with a high-resolution microscope (Olympus BX51). Scale bars, 25 μm. Data (mean values ± SD) represent pooled results or representative images (immunofluorescence and immunoblotting) from three experiments. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, CC versus A+ genotype. None, unstimulated cells. See also [Table S1](#mmc1){ref-type="supplementary-material"}.](gr7){#fig7}

[^1]: Lead Contact
